Ubs Group Ag Venus Concept Inc. Transaction History

Ubs Group Ag

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$0.16 - $6.5 $5,615 - $228,143	35,099 New	35,099 $11,000
Q2 2022 Aug 10, 2022	BUY	$0.45 - $1.57 $3,330 - $11,619	7,401 New	7,401 $3,000
Q1 2022 May 16, 2022	SELL	$1.29 - $1.85 $10,396 - $14,909	-8,059 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.19 - $2.42 $8,470 - $17,225	7,118 Added 756.43%	8,059 $14,000
Q3 2021 Nov 15, 2021	SELL	$1.79 - $3.27 $4,662 - $8,518	-2,605 Reduced 73.46%	941 $2,000
Q2 2021 Aug 13, 2021	SELL	$1.72 - $3.19 $8,629 - $16,004	-5,017 Reduced 58.59%	3,546 $11,000
Q1 2021 May 12, 2021	BUY	$1.73 - $3.33 $3,648 - $7,022	2,109 Added 32.68%	8,563 $20,000
Q4 2020 Feb 11, 2021	BUY	$1.67 - $2.63 $7,650 - $12,048	4,581 Added 244.58%	6,454 $11,000
Q3 2020 Nov 12, 2020	SELL	$2.11 - $3.52 $23,927 - $39,916	-11,340 Reduced 85.82%	1,873 $4,000
Q2 2020 Jul 31, 2020	BUY	$2.52 - $4.76 $32,220 - $60,861	12,786 Added 2994.38%	13,213 $46,000
Q1 2020 May 01, 2020	SELL	$2.35 - $8.2 $7,637 - $26,649	-3,250 Reduced 88.39%	427 $2,000
Q4 2019 Feb 14, 2020	BUY	$2.76 - $8.85 $10,148 - $32,541	3,677 New	3,677 $17,000

Ticker VERO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 65,459,600
Market Cap $19M
Description
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device us...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.